For many years, Clean Cells is an active member of the biotechnology industry by being involved in numerous organizations.

The centre excellence, Atlanpole Biotherapysince its creation in 2000

Clean Cells is an active member, since its creation in 2000, of the centre excellence, Atlanpole Biotherapy, which regroups the abilities of the laboratories, platforms and businesses for a complete service, public/private, knowledgeable and competitive, following through the development of the bio-therapeutic product, right from the target discovery through to its clinical evaluation.

Olivier BOISTEAU, president of Clean Cells, is a member of the administration board, contributes, his support and expertise as Vice-President ”relations extérieures/external relationships” centre.

Leemsince 2004

Research, development, production… biotherapeutic medicine would not exist, without a strong industry which brings its products to fruition. The Biopharmacutical companies, which operate in France, are grouped together under the same organisation: Leem. The President of Clean Cells, Olivier Boisteau is a member of the board of the Biotech Committee, in charge of support and development of biotechnology companies.

Since 2004, Clean Cells brings its solid support, and participates actively with” the Think tank” dedicated to Bio-Production.

ProGreffesince 2008

Since 1993, the Foundation Progreffe, which is a group of sponsors, which support financially the research carried out in Nantes, in the field of renal and pancreatic transplantation.
In 2008, Clean Cells joined them, by supporting financially the actions of the Fondation and their medical teams, in their research into organ transplantation and cell therapy, through the sponsor system.

France BioleadFounding member

Clean Cells (via Clean Biologics) is proud to be one of the 15 founding members of the France BioLead association, whose official launch took place in December 2022.

The France BioLead association represents all players in the French biomanufacturing sector: manufacturers, academic research, training providers, the French government and the various players in the ecosystem.

As a key contact for industry players, the Agence Innovation en Santé and the French government, France BioLead has become the spokesperson for the French production of innovative biomedical products, both nationally and internationally.

In keeping with France 2030, France BioLead’s mission is clear: to make France a European leader in the production of innovative biomedical products, by encouraging technological innovation and accelerating the development of its industrial facilities, in order to guarantee better access for patients in France and throughout the world to the therapeutic innovations of tomorrow.

« We are delighted to be actively involved in France BioLead as part of a pragmatic and enthusiastic founding team to carry forward this ambitious and necessary natio-territorial drive to make our country a strong player in bio-production ! » –  Olivier Boisteau, cofounder of Clean Cells.